Formulation development and evaluation of metformin chewing gum with bitter taste masking


School of Pharmacy and Pharmaceutical Sciences and Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran


Background: Medicated gums are intended to be chewed and act either locally, absorbed via the buccal mucosa or swallowed with saliva. We prepared the metformin gum to overcome its side effects including vomiting, diarrhea, and abdomen discomfort. Furthermore, it could be useful for those who have swallowing problems.
Materials and Methods: Metformin hydrochloride (250 mg) with suitable sweeteners was mixed manually for 5 min. This mixture was spray dried, freeze dried, or directly mixed with chewing gum base. Glycerin, xylitol, and menthol were added and the produced paste was kept in the freezer for 2 h to be stable. As the metformin shows bitter taste, we tried to mask this unpleasant taste with using different methods explained. The releasing pattern was evaluated by using a mechanical chewing machine. The best formulation with the optimized releasing pattern, suitable physicochemical properties and pleasant taste were selected. Content uniformity, releasing percent, and other physicochemical properties were identified as well. Taste, flavor, and appearance characteristics were evaluated by using a self-made questionnaire based on the hedonic test method.
Results: The chewing gum dosage content was about 86.2%. The release rate of metformin chewing gum was about 70% after 5 min of mastication. Masking the bitter taste of drug was achieved by using acesulfame-isomalt as sweeteners and prepared it by freeze drying equipment.
Conclusion: Metfornin chewing gum had suitable appearance and appropriate invitro characteristics that fallow the pharmacopeia suggestions. This chewable gum showed bitterness suppression with a suitable release rate.


1. Rassing MR. Specialized oral mucosal delivery system: Chewing gum. In: Rathbone MJ, editor. Oral Mucosal Drug Delivery. Vol. 24. New York: Marcel Dekker Inc; 1996.p. 319- 357.  Back to cited text no. 1
2. Chaudhary SA, Shahiwala AF. Medicated chewing gum - a potential drug delivery system. Expert Opin Drug Deliv 2010;7:871-85.  Back to cited text no. 2
3. Moore M, Hasler-Nguyen N, Saroea G. In vitro tooth whitening effect of two medicated chewing gums compared to a whitening gum and saliva. BMC Oral Health 2008;8:23.  Back to cited text no. 3
4. Seki M, Karakama F, Kawato T, Tanaka H, Saeki Y, Yamashita Y. Effect of xylitol gum on the level of oral mutans streptococci of preschoolers: Block-randomized trial. Int Dent J 2011;61:274-80.  Back to cited text no. 4
5. Visvanathan V, Nix P. Managing the patient presenting with xerostomia: A review. Int J Clin Pract 2010;64:404-7.  Back to cited text no. 5
6. Jacobsen J, Christrup LL, Jensen NH. Medicated Chewing Gum. Am J Drug Deliv 2004;2:75-88.  Back to cited text no. 6
7. Lingström P, Fure S, Dinitzen B, Fritzne C, Klefbom C, Birkhed D. The release of vitamin C from chewing gum and its effects on supragingival calculus formation. Eur J Oral Sci 2005;113:20-7.  Back to cited text no. 7
8. Tyrpin HT, Russell MP, Witkewitz DL, Johnson SS, Ream RL, Corriveau CL. Caffeine coated chewing gum product and process of making. US Patent 2002;6,444,241.  Back to cited text no. 8
9. Seibel K, Schaffler K, Reitmeir P, Golly L. A randomised, placebo -controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation. Arzneimittelforschun 2002;52:529-36.  Back to cited text no. 9
10. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008;1:CD000146.  Back to cited text no. 10
11. Martindale: The complete drug reference. 36th ed. London; Chicago: The Pharmaceutical Press; 2009. p. 453-4.  Back to cited text no. 11
12. Hashemi SH, Varshosaz J, Emami J. Study of different methods of preparation of the solid dispersion of dimenhydrinate on the drug release from the chewing gum base. Dissertation for granting pharmacy degree. School of pharmacy, Isfahan University of Medical sciences, Isfahan Iran. 1379.  Back to cited text no. 12
13. The United States Pharmacopiea: The national formulary. 31th ed. London, Stationary Office; 2008. p. 366.  Back to cited text no. 13
14. Liljewall LR. Apparatus for mechanical processing of a sample and a member of such an apparatus. 1992: U.S. Patent 5,087,424.  Back to cited text no. 14
15. Dosage Forms, European Pharmacopoeia. 4 th ed. 2002. p. 537.  Back to cited text no. 15
16. Jianchen Xu, Lili B, Kang. Taste masking microspheres for orally disintegrating tablets. Ini J Pharm 2008;359:63-9.  Back to cited text no. 16
17. Szejtli J, Szente L. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextris. Eur J Pharm Biopharm 2005;61:115-25.  Back to cited text no. 17
18. Suzuki H, Onishi H, Takahashi Y, Misamatsu S, Masuda K, Takahashi Y. Acetaminophen Coating chewable tablets with suppressed bitterness and improved oral feeling. Int J Pharm 2004;278:51-61.  Back to cited text no. 18
19. Suzuki M, Onishi M, Takashi Y. Development of oral acetaminophen chewable tablets with inhibited bitter taste. Int J Pharm 2002;251:123-32.  Back to cited text no. 19
20. Sharma V, Chopra H. Role of taste and taste masking of bitter drugs in pharmaceutical industries: An overview. Int J Pharm Pharm Sci. 2010;2:14-18.  Back to cited text no. 20
21. Sheppard BH, Hartwick J,Warshaw PR. The theory of reasoned action: A meta-analysis of past research with recommendations for modifications and future research. JCR 1988;15:325-43.  Back to cited text no. 21
22. Stone H, Side JL. Sensory Evaluation Practices. 3 th ed. San Diago; CA: 2004.  Back to cited text no. 22
23. Meilgard M, Civille G, Thomas B. Sensory evaluation techniques. 4th ed. Boca Raton: CRC Publishers; 2007.  Back to cited text no. 23
24. Rathbone MJ, Hadgraft J, Roberts MS. Modified-release drug delivery technology. New York: Marcel Dekker; 2002. p. 1-8.  Back to cited text no. 24
25. Rassing MR, Jacobsen J, Nielsen HM. Chewing gum as a drug delivery system. 2th ed. Copenhagen, Denmark: Ellermann Carecom International; 2003.  Back to cited text no. 25
26. Pokharkar VB, Kshrisagar SJ, Fatima L. Tastemasking of pharmaceuticals. Article posted on Ind J Pharm Sci 2002; 64:10-17.  Back to cited text no. 26
27. Sohi H, Sultana Y, Khar R. Taste masking technologies in oral pharmaceuticals: Recent Developments and Approaches. Drug Dev Ind Pharm 2004;30:429-48.  Back to cited text no. 27
28. Sugao H. Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax coated microparticles. J Microencapsul 1999;16:565-71.  Back to cited text no. 28
29. Gedam SS, Tapar KK. Taste masking and characterization of diphenhydramine hydrochloride by spray drying technique. Int J Pharm 2010;1:3.  Back to cited text no. 29
30. Devireddy SR, Gonugunta CS, Veerareddy PR. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets. PDA J Pharm Sci Technol 2009;63:521-6.  Back to cited text no. 30
31. Pandya SP: Compatible Polymer used as complexes in various drug delivery systems : β Cyclodextrin. Pharma 2008;6:33-8.  Back to cited text no. 31
32. Sajal JK. Taste masking in pharmaceuticals. Int J Pharm 2008;1:126-30.  Back to cited text no. 32
33. Chatap, V. K.; Gupta, V. B.; Sharma, D. K.; Nandgude, T. D. A review on taste masking methods for bitter drug. Pharmainfo. net 2007;5:1.  Back to cited text no. 33